Radiopharm Theranostics (RADX) Invested Capital (2024 - 2025)
Radiopharm Theranostics (RADX) reported Invested Capital of $32.4 million for Q2 2025, up 17858.51% year-over-year from N/an in Q2 2024, and up 17858.51% quarter-over-quarter from $180264.9 in Q2 2024.
Radiopharm Theranostics (RADX) Invested Capital (2024 - 2025) Analysis & Trends
Radiopharm Theranostics (RADX) has 2 years of Invested Capital data on file, last reported at $32.4 million in Q2 2025.
- Invested Capital for Q2 2025 came in at $32.4 million, up 17858.51% year-over-year; the trailing twelve-month figure through Jun 2025 was $32.4 million (up 17858.51% YoY), and the FY2025 annual result was $75.0 million, up 41488.93% from the prior year.
- Invested Capital grew to $32.4 million in Q2 2025 per RADX's latest filing, from $180264.9 in the prior quarter.
- Over five years, Invested Capital peaked at $32.4 million in Q2 2025 and troughed at $180264.9 in Q2 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Invested Cap. (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | 7.14 Bn |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | 795.79 Mn |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | 595,226.00 |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 1.00 Bn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | 14.38 Mn |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 19.36 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | 502.95 Mn |
| 10 | Radiopharm Theranostics | 5.82 Bn | 5.81 Bn | - | 32.37 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2025 | 32.37 Mn |
| Jun 30, 2024 | 180,264.85 |